Yahoo Web Search

Search results

  1. COVID-19 Treatment Guidelines. About the Guidelines. Overview. Management. Therapies. Special Populations. Final Coronavirus Disease (COVID-19) Treatment Guidelines (February 29, 2024) SEE FINAL UPDATE. Credit NIAID-RML. Highlighted Sections. Nonhospitalized Adults: Therapeutic Management.

    • Overview
    • Treating COVID-19
    • Preventing COVID-19

    Updated Jan. 18, 2024

    Print

    •If you have COVID-19 and are more likely to get very sick from COVID-19, treatments are available that can reduce your risk of hospitalization and death.

    •Don’t delay: Treatment must be started within 5-7 days after you first develop symptoms.

    •Other medications can help reduce symptoms and help you manage your illness.

    •The Treatment Locator (hhs.gov) can help you find a location that offers testing and treatment or a pharmacy where you can fill your prescription.

    Most people with COVID-19 have mild illness and can recover at home. You can treat symptoms with over-the-counter medicines, such as acetaminophen or ibuprofen, to help feel better.

    If you have COVID-19 and are more likely to get very sick from COVID-19, treatments are available that can reduce your chances of being hospitalized or dying from the disease. Medications to treat COVID-19 must be prescribed by a healthcare provider or pharmacist and started within 5–7 days after symptoms appear. Contact a healthcare provider right away to determine if you are eligible for treatment, even if your symptoms are currently mild.

    Don’t delay: Treatment must be started within 5–7 days of when you first develop symptoms.

    People who are more likely to get very sick include

    •older adults (ages 50 years or older, with risk increasing with age),

    •people who are unvaccinated or are not up to date on their COVID-19 vaccinations,

    COVID-19 vaccines

    To find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. Last Updated Jan. 18, 2024 Source: National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

  2. Apr 11, 2020 · COVID-19 Guideline, Part 2: Infection Prevention. COVID-19 Guideline, Part 3: Molecular Testing. COVID-19 Guideline, Part 4: Serologic Testing. COVID-19 Guideline, Part 5: Antigen Testing. Management of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid®): Resource for Clinicians.

  3. Aug 4, 2023 · NIH COVID-19 Treatment Guidelines: Panel recommendations for management of patients with COVID-19. NIH COVID-19 Treatment Guidelines – Special Populations: Summary recommendations including patients with possible influenza and COVID-19.

  4. Oct 27, 2021 · Published October 27, 2021. N Engl J Med 2021;385: 1941 - 1950. DOI: 10.1056/NEJMoa2107934. VOL. 385 NO. 21. Abstract. Background. Coronavirus disease 2019 (Covid-19) disproportionately results...

  1. People also search for